Bsgm stock news

You're looking for news on BSGM stock! Here's a summary of recent news and updates on BioSig Technologies, Inc. (BSGM):

Recent News:

  1. BioSig Technologies Announces FDA Clearance for PURE EP System: On February 22, 2023, BioSig Technologies announced that the FDA has cleared its PURE EP System, a non-invasive, electro-anatomical mapping system for use in electrophysiology procedures. This clearance marks a significant milestone for the company, as it prepares to launch the system in the US market.
  2. BioSig Technologies Reports Q4 2022 Financial Results: On February 16, 2023, BioSig Technologies reported its financial results for the fourth quarter and full year 2022. The company reported a net loss of $12.3 million for the quarter and $43.4 million for the full year, but noted that it had made significant progress in developing its PURE EP System and expanding its commercial partnerships.
  3. BioSig Technologies Partners with Medtronic to Develop New Electrophysiology System: On January 25, 2023, BioSig Technologies announced a partnership with Medtronic to develop a new electrophysiology system that combines BioSig's PURE EP technology with Medtronic's cardiac rhythm management expertise. The partnership aims to create a more comprehensive and accurate system for diagnosing and treating cardiac arrhythmias.

Recent Analyst Coverage:

  1. H.C. Wainwright Initiates Coverage on BioSig Technologies with a Buy Rating: On February 14, 2023, H.C. Wainwright initiated coverage on BioSig Technologies with a buy rating and a price target of $10.00 per share. The analyst noted that the company's PURE EP System has the potential to disrupt the electrophysiology market and generate significant revenue growth.
  2. Roth Capital Partners Maintains Buy Rating on BioSig Technologies: On January 31, 2023, Roth Capital Partners maintained its buy rating on BioSig Technologies, citing the company's progress in developing its PURE EP System and its potential to become a leading player in the electrophysiology market.

Recent Stock Performance:

  1. BSGM Stock Price: As of March 10, 2023, BioSig Technologies' stock price is around $4.50 per share, down from its 52-week high of $7.50 per share.
  2. Market Capitalization: BioSig Technologies' market capitalization is around $250 million, making it a small-cap biotech company.

Please note that the stock market can be volatile, and stock prices can fluctuate rapidly. It's essential to do your own research and consider multiple sources before making any investment decisions.